OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing tsMHCII-mediated Immune Recognition
Jingtai Zhi, Peitao Zhang, Wei Zhang, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 106, Iss. 1, pp. 91-107
Open Access | Times Cited: 26
Jingtai Zhi, Peitao Zhang, Wei Zhang, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 106, Iss. 1, pp. 91-107
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
Wei Zhang, Xianhui Ruan, Yaoshuang Li, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1500-1517
Open Access | Times Cited: 72
Wei Zhang, Xianhui Ruan, Yaoshuang Li, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1500-1517
Open Access | Times Cited: 72
Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
Peitao Zhang, Haixia Guan, Shukai Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Peitao Zhang, Haixia Guan, Shukai Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Pathogenesis of cancers derived from thyroid follicular cells
James A. Fagin, Gnana P. Krishnamoorthy, Iñigo Landa
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 631-650
Open Access | Times Cited: 29
James A. Fagin, Gnana P. Krishnamoorthy, Iñigo Landa
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 631-650
Open Access | Times Cited: 29
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
Kristian M. Hargadon
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 12
Kristian M. Hargadon
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 12
Programmed cell death-related gene IL20RA facilitates tumor progression and remodels tumor microenvironment in thyroid cancer
Haijun Yu, Yunlong Zhang, Min Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Haijun Yu, Yunlong Zhang, Min Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
Xiaomeng Guo, Junqiang Bai, Xinmiao Wang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114576-114576
Closed Access
Xiaomeng Guo, Junqiang Bai, Xinmiao Wang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114576-114576
Closed Access
Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5803-5803
Open Access | Times Cited: 8
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5803-5803
Open Access | Times Cited: 8
New Insights into Immune Cells and Immunotherapy for Thyroid Cancer
Yujia Tao, Peng Li, Chao Feng, et al.
Immunological Investigations (2023) Vol. 52, Iss. 8, pp. 1039-1064
Closed Access | Times Cited: 7
Yujia Tao, Peng Li, Chao Feng, et al.
Immunological Investigations (2023) Vol. 52, Iss. 8, pp. 1039-1064
Closed Access | Times Cited: 7
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation
Mark Lee, Luc G.T. Morris
Oncotarget (2024) Vol. 15, Iss. 1, pp. 36-48
Open Access | Times Cited: 2
Mark Lee, Luc G.T. Morris
Oncotarget (2024) Vol. 15, Iss. 1, pp. 36-48
Open Access | Times Cited: 2
Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms
Qian-Qian Xu, Jiaqi Wang, Yuting Mao, et al.
Neoplasia (2024) Vol. 52, pp. 100996-100996
Open Access | Times Cited: 2
Qian-Qian Xu, Jiaqi Wang, Yuting Mao, et al.
Neoplasia (2024) Vol. 52, pp. 100996-100996
Open Access | Times Cited: 2
E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression
Cuihong Jiang, Lili He, Shuai Xiao, et al.
Molecular Biotechnology (2022) Vol. 65, Iss. 6, pp. 891-903
Closed Access | Times Cited: 9
Cuihong Jiang, Lili He, Shuai Xiao, et al.
Molecular Biotechnology (2022) Vol. 65, Iss. 6, pp. 891-903
Closed Access | Times Cited: 9
Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer
Zhen Luo, Jin Xu, Dayong Xu, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 5
Zhen Luo, Jin Xu, Dayong Xu, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 5
Biopolymer Immune Implants co-loaded with TMZ, R848 and IOX1 for Perioperative Therapy of Glioblastoma
Pinxin Lv, Zhanfeng Wang, Xinghui Si, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
Pinxin Lv, Zhanfeng Wang, Xinghui Si, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
High Expression of THBS1 Leads to a Poor Prognosis in Papillary Thyroid Cancer and Suppresses the Anti-Tumor Immune Microenvironment
Anqi Jin, Jin Zhou, Pengcheng Yu, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 6
Anqi Jin, Jin Zhou, Pengcheng Yu, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 6
Minimal change disease associated with thyroid cancer: a case report
Xiaoyi Cai, Yuenv Wu, Qijun Wan, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Xiaoyi Cai, Yuenv Wu, Qijun Wan, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Targeting SHP2 sensitizes differentiated thyroid carcinoma to the MEK inhibitor.
Jingtai Zhi, Jiaoyu Yi, Xiukun Hou, et al.
PubMed (2022) Vol. 12, Iss. 1, pp. 247-264
Closed Access | Times Cited: 5
Jingtai Zhi, Jiaoyu Yi, Xiukun Hou, et al.
PubMed (2022) Vol. 12, Iss. 1, pp. 247-264
Closed Access | Times Cited: 5
Immune-Related LncRNAs Affect the Prognosis of Osteosarcoma, Which Are Related to the Tumor Immune Microenvironment
Qingshan Huang, Yilin Lin, Chenglong Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 7
Qingshan Huang, Yilin Lin, Chenglong Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 7
Th9 Cytokines Inhibit Proliferation, Promote Apoptosis, and Immune Escape in Thyroid Carcinoma Cells
Xinyu Ying, Xinyi Ma, Ziru Yang, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access
Xinyu Ying, Xinyi Ma, Ziru Yang, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression
Ana-Maria Chindris, Michael Rivera, Yaohua Ma, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Ana-Maria Chindris, Michael Rivera, Yaohua Ma, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Harnessing Immunity to Treat Advanced Thyroid Cancer
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
Th9 cytokines inhibit proliferation, promote apoptosis, and immune escape in thyroid carcinoma cells
Xinyu Ying, Xinyi Ma, Ziru Yang, et al.
Research Square (Research Square) (2023)
Open Access
Xinyu Ying, Xinyi Ma, Ziru Yang, et al.
Research Square (Research Square) (2023)
Open Access
Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
延泽 刘
Advances in Clinical Medicine (2022) Vol. 12, Iss. 09, pp. 8499-8507
Closed Access
延泽 刘
Advances in Clinical Medicine (2022) Vol. 12, Iss. 09, pp. 8499-8507
Closed Access
Genetic Dysregulation of Immunologic and Oncogenic Signaling Pathways Associated with Tumor-intrinsic Immune Resistance: A Molecular Basis for Combination Targeted Therapy-Immunotherapy for Cancer
Kristian M. Hargadon
Research Square (Research Square) (2022)
Open Access
Kristian M. Hargadon
Research Square (Research Square) (2022)
Open Access
